Novartis AG (NVS) Earnings History
Annual and quarterly earnings data from 1998 to 2025
Loading earnings history...
NVS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NVS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 75.0% | 31.2% | 25.6% |
| 2024 | 75.2% | 28.1% | 23.1% |
| 2023 | 73.3% | 20.9% | 31.8% |
| 2022 | 73.4% | 18.3% | 16.0% |
| 2021 | 73.3% | 22.9% | 54.6% |
Download Data
Export NVS earnings history in CSV or JSON format
Free sign-in required to download data
Novartis AG (NVS) Earnings Overview
As of May 6, 2026, Novartis AG (NVS) reported trailing twelve-month net income of $13.53B, reflecting +22.5% year-over-year growth. The company earned $7.06 per diluted share over the past four quarters, with a net profit margin of 25.6%.
Looking at the long-term picture, NVS's 5-year EPS compound annual growth rate (CAGR) stands at +15.4%, indicating exceptional earnings growth. The company achieved its highest annual net income of $24.02B in fiscal 2021.
Novartis AG maintains industry-leading profitability with a gross margin of 75.0%, operating margin of 31.2%, and net margin of 25.6%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including PFE ($7.49B net income, 12.4% margin), AZN ($10.39B net income, 17.5% margin), NVO ($98.50B net income, 33.1% margin), NVS has outperformed on profitability metrics. Compare NVS vs PFE →
NVS Earnings vs Peers
Earnings metrics vs comparable public companies
NVS Historical Earnings Data (1998–2025)
28 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $14.06B | +17.7% | $17.07B | $7.19 | 25.6% | 31.2% |
| 2024 | $11.94B | -19.6% | $14.54B | $5.87 | 23.1% | 28.1% |
| 2023 | $14.85B | +113.5% | $9.77B | $7.10 | 31.8% | 20.9% |
| 2022 | $6.96B | -71.0% | $7.95B | $3.17 | 16.0% | 18.3% |
| 2021 | $24.02B | +197.6% | $10.06B | $10.63 | 54.6% | 22.9% |
| 2020 | $8.07B | -31.2% | $10.15B | $3.52 | 16.2% | 20.3% |
| 2019 | $11.73B | -7.0% | $9.09B | $3.08 | 24.1% | 18.7% |
| 2018 | $12.61B | +63.7% | $8.40B | $5.38 | 27.4% | 18.2% |
| 2017 | $7.70B | +14.8% | $8.70B | $3.25 | 17.7% | 20.0% |
| 2016 | $6.71B | -62.3% | $8.27B | $2.80 | 13.6% | 16.7% |
Full NVS Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy NVS Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See NVS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NVS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNVS — Frequently Asked Questions
Quick answers to the most common questions about buying NVS stock.
Is NVS growing earnings?
NVS EPS is $7.06, with earnings growth accelerating to +22.5%. This exceeds the 5-year CAGR of +15.4%. TTM net income reached $13.5B.
What are NVS's profit margins?
Novartis AG net margin is +25.6%, with operating margin at +31.2%. Above-average margins indicate pricing power.
How consistent are NVS's earnings?
NVS earnings data spans 1998-2025. The accelerating earnings trend is +22.5% YoY. Historical data enables comparison across business cycles.